Mauro Saieg

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial

Cesare Gridelli, Fortunato Ciardiello, Ciro Gallo et al. · Journal of Clinical Oncology · 2012 · 232 citations · Full text

Loss of Phosphatase and Tensin Homolog Protein Expression Is an Independent Poor Prognostic Marker in Lung Adenocarcinoma

Naoki Yanagawa, Charles Leduc, Derek M. Kohler et al. · Journal of Thoracic Oncology · 2012 · 55 citations · Full text

Prognostic Biomarkers, Tumor Microenvironment, Medicine +8

Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: Review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype

Gilda da Cunha Santos, Shui Wun Lai, Mauro Saieg et al. · Lung Cancer · 2012 · 41 citations

Surgical Oncology, Medicine, Year Period +12

The use of FTA cards for preserving unfixed cytological material for high‐throughput molecular analysis

Mauro Saieg, William R. Geddie, Scott Boerner et al. · Cancer Cytopathology · 2012 · 39 citations · Full text

The impact of rapid on‐site evaluation on thyroid fine‐needle aspiration biopsy: A 2‐year cancer center institutional experience

Ricardo Pastorello, Camila Destefani, Pedro Henrique Nicolau Pinto et al. · Cancer Cytopathology · 2018 · 34 citations · Full text